Compare PEPG & GOAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | GOAI |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.7M | 118.7M |
| IPO Year | 2022 | N/A |
| Metric | PEPG | GOAI |
|---|---|---|
| Price | $1.47 | $3.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $11.17 | N/A |
| AVG Volume (30 Days) | ★ 801.1K | 101.0K |
| Earning Date | 05-14-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $2.75 |
| 52 Week High | $7.80 | $6.67 |
| Indicator | PEPG | GOAI |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 38.69 |
| Support Level | $1.32 | N/A |
| Resistance Level | $5.37 | $4.36 |
| Average True Range (ATR) | 0.12 | 0.32 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 21.11 | 17.86 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.